tiprankstipranks

Nevro price target lowered to $8 from $11 at Canaccord

Canaccord lowered the firm’s price target on Nevro to $8 from $11 and keeps a Hold rating on the shares. The firm said they reported a Q2 miss and reduced its FY24 outlook.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue